Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Esther, Tahover"'
Autor:
Suyog Jain, Shaheenah Dawood, Viraj Lavingia, Dan Aderka, Esther Tahover, Yao-Yu Hsieh, Mark Temper, Alesya Goldman, Marwan AI. Akasheh, Steve Olsen, Sandra San Hsing, Nisarg Joshi, Hsiao-Yu Jen
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionThe presence of minimal residual disease (MRD) after curative-intent surgery for early-stage cancers is associated with disease recurrence. Circulating tumour deoxyribonucleic acid (ctDNA) has emerged as a promising biomarker for MRD asse
Externí odkaz:
https://doaj.org/article/c91aaac94d5c4fdb9f6f21289320c8f0
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background Early detection of colorectal cancer (CRC) improves prognosis, yet many CRCs are diagnosed following symptoms. The aim of this study was to determine which CRC-related symptoms or signs can predict an advanced CRC in the pre-opera
Externí odkaz:
https://doaj.org/article/36b2ca5daa59485987743f53e02b8fd1
Autor:
Albert Grinshpun, Anatoli Kustanovich, Daniel Neiman, Roni Lehmann‐Werman, Aviad Zick, Karen Meir, Elez Vainer, Roy Z. Granit, Amit Arad, Noa Daskal, Ruth Schwartz, Eli Sapir, Myriam Maoz, Esther Tahover, Joshua Moss, Iddo Z. Ben‐Dov, Tamar Peretz, Ayala Hubert, Ruth Shemer, Yuval Dor
Publikováno v:
International Journal of Cancer. 152:1444-1451
The standard treatment approach for stage II/III rectal cancer is neoadjuvant chemoradiation therapy (nCRT) followed by surgery. In recent years, new treatment approaches have led to higher rates of complete tumor eradication combined with organ-pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbde990a132d93673c7efd12f5648a9a
https://doi.org/10.1002/ijc.34392
https://doi.org/10.1002/ijc.34392
Autor:
Esther Tahover, Rachel Bar-Shalom, Eli Sapir, Raphael Pfeffer, Igor Nemirovsky, Yehonatan Turner, Maya Gips, Patricia Ohana, Benjamin W. Corn, Andrew Z. Wang, Alberto A. Gabizon
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Hypo-fractionated radiotherapy and stereotactic body radiotherapy are viable options for treatment of oligometastases. A prodrug of mitomycin-C is under clinical testing as a pegylated liposomal formulation (Promitil) with an improved safety profile
Externí odkaz:
https://doaj.org/article/87f8258574924f4cbea1e191568dfb81
Autor:
Hilary Shmeeda, Yasmine Amitay, Alberto Gabizon, Patricia Ohana, Talia Golan, Ravit Geva, Esther Tahover, Ruth Perets
Publikováno v:
Investigational New Drugs. 38:1411-1420
Background Pegylated liposomal (PL) mitomycin-c lipidic prodrug MLP) may be a useful agent in patients with metastatic colo-rectal carcinoma (CRC). We report here on the pharmacokinetics and clinical observations in a phase 1A/B study with PL-MLP. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55854abbb3aa55087e1cc60601321d35
https://doi.org/10.1007/s10637-020-00897-3
https://doi.org/10.1007/s10637-020-00897-3
Introduction: Early detection of colorectal cancer (CRC) improves prognosis, yet many CRCs are diagnosed following symptoms. The aim of this study was to determine which CRC-related symptoms or signs can predict an advanced CRC in the pre-operative s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f7a296da0250935e95dff94251ad560
https://doi.org/10.21203/rs.3.rs-686958/v1
https://doi.org/10.21203/rs.3.rs-686958/v1
Autor:
Esther Tahover, M Benhaim, Dan M. Livovsky, A Dancour, J Schifter, Eran Goldin, Talia Golan, G Sheykman
Publikováno v:
ESGE Days 2021.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab884eb803f161a72e7ad78f78b6de89
https://doi.org/10.1055/s-0041-1724299
https://doi.org/10.1055/s-0041-1724299
Autor:
Yogita Patil, Samuel Zalipsky, Yasmine Amitay, Gleb Kornev, Alberto Gabizon, Esther Tahover, Eli Sapir, Hilary Shmeeda, Patricia Ohana
Publikováno v:
Advanced drug delivery reviews.
Several liposome products have been approved for the treatment of cancer. In all of them, the active agents are encapsulated in the liposome water phase passively or by transmembrane ion gradients. An alternative approach in liposomal drug delivery c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ebe81149863eac6a342825571c6eac
https://pubmed.ncbi.nlm.nih.gov/32777239
https://pubmed.ncbi.nlm.nih.gov/32777239
Autor:
Alberto A, Gabizon, Esther, Tahover, Talia, Golan, Ravit, Geva, Ruth, Perets, Yasmine, Amitay, Hilary, Shmeeda, Patricia, Ohana
Publikováno v:
Investigational new drugs. 38(5)
Background Pegylated liposomal (PL) mitomycin-c lipidic prodrug MLP) may be a useful agent in patients with metastatic colo-rectal carcinoma (CRC). We report here on the pharmacokinetics and clinical observations in a phase 1A/B study with PL-MLP. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62d34fa4a7fd6256204fb29dc4b2e767
https://pubmed.ncbi.nlm.nih.gov/31955309
https://pubmed.ncbi.nlm.nih.gov/31955309
Publikováno v:
Anti-Cancer Drugs. 27:569-572
Here, we present a case of an 84-year-old woman who developed obstructive jaundice and was diagnosed with nonoperable adenocarcinoma originating from the ampulla of Vater, a lethal disease with a median overall survival of less than a year. Her tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cefa816ce15386157ff11cdea05bc11
https://doi.org/10.1097/cad.0000000000000355
https://doi.org/10.1097/cad.0000000000000355